Logo for the University of Illinois at Chicago
    • Login
    View Item 
    •   INDIGO Home
    • Dissertations and Theses at UIC
    • UIC Dissertations and Theses
    • View Item
    •   INDIGO Home
    • Dissertations and Theses at UIC
    • UIC Dissertations and Theses
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Bioactivation Studies of Novel SERMs, LY2066948 and Lasofoxifene, to Reactive Quinoids using LC-MS/MS

    Thumbnail
    View/Open
    Gherezghiher_Teshome.pdf (3.345Mb)
    Date
    2012-12-10
    Author
    Gherezghiher, Teshome B.
    Metadata
    Show full item record
    Abstract
    o-Quinone forming estrogens and selective estrogen receptor modulators (SERMs) have been associated with carcinogenesis. Long-term usage of tamoxifen has been associated with an increased risk of endometrial cancer. One potential mechanism of tamoxifen induced carcinogenesis involves metabolism to highly reactive carbocation intermediate, which could cause DNA damage through the formation of DNA adducts. In the present study, the potential for LY2066948 and lasofoxifene (LAS), to form electrophilic/redox active intermediates were investigated. In addition, the bioactivation of estrogens also explored for comparison in this study. LY2066948, a novel SERM in development by Eli Lilly for the treatment of uterine fibroids or myomas, has structural similarity to the equine estrogen equilenin present in hormone replacement formulations; both contain a naphthol group susceptible to oxidative metabolism to o-quinones. In model reactions with tyrosinase, the catechol metabolites of LY2066948 and equilenin were products; interestingly, in the presence of ascorbate to inhibit autoxidation, these catechols were formed quantitatively. Tyrosinase incubations in the presence of GSH gave the expected GSH conjugates resulting from trapping of the o-quinones, which were characterized by LC-MS/MS. Incubations of LY2066948 or equilenin with rat liver microsomes also gave detectable o-quinone trapped GSH conjugates; however, as observed with other SERMs, oxidative metabolism of LY2066948 mainly occurred on the amino side chain to yield the N-dealkylated metabolite. These studies suggest that although the naphthol group is susceptible to oxidative metabolism to long-lived o-quinones, the formation of these quinones by P450 can be attenuated by the chemistry of the remainder of the molecule as in the case of LY2066948. LAS is a third generation SERM, which has completed phase III clinical trials for osteoporosis prevention and treatment. However, since LAS has a polyaromatic phenol scaffold similar to endogenous estrogens, it has been hypothesized that LAS can form reactive quinoid metabolites. In this study, LAS was synthesized as a racemic mixture and its oxidative metabolism was investigated using various oxidative enzymes. Incubation of LAS with tyrosinase or rat liver microsomes in the presence of GSH gave two mono-GSH and two di-GSH conjugates, formed from trapping of the o-quinones. In addition, o-quinones GSH conjugates of LAS were also detected from the incubation of CYP3A4, CYP2D6 and CYP1B1 supersomes. These data show that, like endogenous estrogens, LAS is oxidized to catechols and o-quinones which could potentially cause toxicity in vivo.
    Subject
    Estrogen
    Equilenin
    LY2066948
    Lasofoxifene
    Cytochrome P450
    o-Quinone
    SERM
    Selective estrogen receptor modulator
    Type
    thesis
    text
    Date available in INDIGO
    2012-12-10T16:51:53Z
    URI
    http://hdl.handle.net/10027/9209
    Collections
    • UIC Dissertations and Theses

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV

    Browse

    All of INDIGOCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    DSpace software copyright © 2002-2015  DuraSpace
    Contact Us | Send Feedback | Privacy Statement
    Theme by 
    Atmire NV